Beranda › Mielofibrosis
Uji klinis Mielofibrosis yang merekrut di AS
56 studi untuk Mielofibrosis merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- Houston, TX19 studi
- New York City, NY18 studi
- Boston, MA12 studi
- Durham, NC12 studi
- Columbus, OH11 studi
- Seattle, WA11 studi
- Miami, FL10 studi
- Salt Lake City, UT10 studi
- Tampa, FL9 studi
- Atlanta, GA9 studi
- Cleveland, OH9 studi
- Baldwin Park, CA9 studi
- Nashville, TN9 studi
- St. Louis, MO8 studi
- Ann Arbor, MI8 studi
- Mountain View, CA7 studi
- Chicago, IL7 studi
- Baltimore, MD7 studi
- Birmingham, AL7 studi
- Winston-Salem, NC6 studi
- Los Angeles, CA6 studi
- Philadelphia, PA6 studi
- Irvine, CA5 studi
- Portland, OR5 studi
- Kansas City, MO5 studi
- Dallas, TX5 studi
- Cincinnati, OH5 studi
- Jacksonville, FL4 studi
- Edison, NJ4 studi
- Milwaukee, WI4 studi
- Minneapolis, MN4 studi
- Charlotte, NC4 studi
- Denver, CO4 studi
- New Haven, CT4 studi
- Washington, DC4 studi
- Gilbert, AZ3 studi
- Aurora, CO3 studi
- Orange, CA3 studi
- Coral Springs, FL3 studi
- Sacramento, CA3 studi
Berdasarkan negara bagian
- Alabama7 studi
- Arizona7 studi
- California21 studi
- Colorado6 studi
- Connecticut5 studi
- Florida14 studi
- Georgia9 studi
- Illinois7 studi
- Kansas6 studi
- Maryland9 studi
- Massachusetts13 studi
- Michigan10 studi
- Minnesota7 studi
- Missouri8 studi
- New Jersey6 studi
- New York21 studi
- North Carolina17 studi
- Ohio17 studi
- Oregon6 studi
- Pennsylvania8 studi
- South Carolina4 studi
- Tennessee9 studi
- Texas20 studi
- Utah10 studi
- Virginia5 studi
- Washington11 studi
- Wisconsin5 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07469891A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07357727A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07623161Tolerability of Ropeginterferon Alfa-2b Add-on to Ongoing Ruxolitinib Therapy in Myelofibrosis
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07521046A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06661915Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
Menerima pesertaFase awal 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06398457Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT05320198A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT04176198A Phase 1 Study of LY5830966 in Participants With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT06343805Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT04282187High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients With Splenomegaly
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT06345495Pacritinib Effectiveness in Real-world Settings
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT07774455A Telehealth Advance Care Planning Intervention
Menerima peserta
Usia 60 ke atas · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT05875805Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT07228624TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT
Menerima pesertaFase 1
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT07302776A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Agu 2026 · NCT07008118Quantitative MRI for Myelofibrosis
Menerima pesertaStudi observasional
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 31 Jul 2026 · NCT01973881A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 28 Jul 2026 · NCT07020533A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Jul 2026 · NCT06773195Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Jul 2026 · NCT07441694A Study of Rebecsinib for Patients With Relapsed/Refractory Secondary Acute Myeloid Leukemia or High Risk Myelofibrosis
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Jul 2026 · NCT07250646Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary Myelofibrosis
Menerima pesertaFase 2
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 20 Jul 2026 · NCT04370301Phase I/II Clinical Trial of Axatilimab, a CSF1R Monoclonal Antibody, in Combination With Ruxolitinib as Therapy for Patients With Myelofibrosis (MF) and Chronic Myelomonocytic Leukemia (CMML)
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Jul 2026 · NCT07128381Allo HSCT Using RIC and PTCy for Hematological Diseases
Menerima pesertaFase 2
Hingga usia 75 · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT05805605Registry of Older Patients With Cancer
Menerima pesertaStudi observasional
Usia 65 ke atas · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT01137825Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.